CD44 and cancer: To evaluate the impact of combination treatment on the stemness of the B-CPAP cells, mRNA fold changes of the NANOG, SOX2, CD44, and CD133 genes, key regulators of the stemness and self-renewal of cancer cells, were investigated using qRT-PCR.